Cost-effectiveness model for first-trimester versus second-trimester ultrasound screening for Down syndrome

Journal of the American College of Radiology

Volumn 1, Issue 6, 2004, Pages 415-421

  Kott, Brian ^a   Dubinsky, Theodore J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cost effectiveness; Down syndrome; First trimester screening; Second trimester screening; Ultrasound

Indexed keywords

ABORTION; ALGORITHM; AMNIOCENTESIS; ARTICLE; CHORION VILLUS SAMPLING; COMPUTER PROGRAM; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DOWN SYNDROME; FETUS DEATH; FETUS ECHOGRAPHY; FETUS WASTAGE; FIRST TRIMESTER PREGNANCY; HEALTH CARE COST; MEDICARE; PREVALENCE; REIMBURSEMENT; SECOND TRIMESTER PREGNANCY; SEROLOGY;

EID: 84928096478     PISSN: 15461440     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacr.2004.01.020     Document Type: Article

References (24)

1. Wegmann B, Huch R, Huch A, Zimmerman R. Prenatal ultrasonography in Switzerland - a representative national survey. Ultraschall Med. 21:(5):2000;210-217. [in German]
2. Dubbins P.A. Screening for chromosomal abnormality. Semin Ultrasound CT MR. 19:(4):1998;310-317
3. Crane J.P, LeFevre M.L, Winborn R.C, et al. A randomized trial of prenatal ultrasonographic screening: impact on the detection, management, and outcome of anomalous fetuses. The RADIUS Study Group. Am J Obstet Gynecol. 171:(2):1994;392-399
4. Vintzileos A.M, Ananth C.V, Smulian J.C, Beazoglou T, Knuppel R.A. Routine second trimester ultrasonography in the United States a cost-benefit analysis. Am J Obstet Gynecol. 182:(3):2000;655-660
5. Vintzileos A.M, Ananth C.V, Fisher A.J, et al. An economic evaluation of second trimester genetic ultrasonography for prenatal detection of Down syndrome. Am J Obstet Gynecol. 179:(5):1998;1214-1219
6. Seeds J.W. The routine or screening obstetrical ultrasound examination. Clin Obstet Gynecol. 39:(4):1996;814-830
7. Cusick W, Vintzileos A.M. Fetal Down syndrome screening a cost effectiveness analysis of alternative screening programs. J Matern Fetal Med. 8:(6):1999;243-248
8. Beazoglou T, Heffley D, Kyriopoulos J, Vintzileos A, Benn P. Economic evaluation of prenatal screening for Down syndrome in the U.S.A. Prenat Diagn. 18:(12):1998;1241-1252
9. Nyberg D.A, Souter V.L, El-Bastawissi A, Young S, Luthhardt F, Luthy D.A. Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy. J Ultrasound Med. 20:(10):2001;1053-1063
10. Nyberg D.A, Souter V.L. Sonographic markers of fetal trisomies second trimester. J Ultrasound Med. 20:(6):2001;655-674
11. Winter T.C, Uhrich S.B, Souter V.L, Nyberg D.A. The "genetic sonogram:" comparison of the index scoring system with the age-adjusted US risk assessment. Radiology. 215:(3):2000;775-782
12. Souter V.L, Nyberg D.A, El-Bastawissi A, Zebelman A, Luthhardt F, Luthy D.A. Correlation of ultrasound findings and biochemical markers in the second trimester of pregnancy in fetuses with trisomy 21. Prenat Diagn. 22:(3):2002;175-182
13. Souter V.L, Nyberg D.A. Sonographic screening for fetal aneuploidy first trimester. J Ultrasound Med. 20:(7):2001;775-790
14. Morris J.K, Wald N.J, Watt H.C. Fetal loss in Down syndrome pregnancies. Prenat Diagn. 19:(2):1999;142-145
15. Bray I.C, Wright D.E. Estimating the spontaneous loss of Down syndrome fetuses between the times of chorionic villus sampling, amniocentesis and livebirth. Prenat Diagn. 18:(10):1998;1045-1054
16. Heckerling P.S, Verp M.S. A cost-effectiveness analysis of amniocentesis and chorionic villus sampling for prenatal genetic testing. Med Care. 32:(8):1994;863-880
17. Medverd J.R, Dubinsky T.J. Cost analysis model US versus endometrial biopsy in evaluation of peri- and postmenopausal abnormal vaginal bleeding. Radiology. 222:(3):2002;619-627
18. Vintzileos A.M, Ananth C.V, Fisher A.J, Smulian J.C, Day-Salvatore D.L, Beazoglou T. An economic evaluation of first-trimester genetic sonography for prenatal detection of Down syndrome. Obstet Gynecol. 91:(4):1998;535-539
19. Cusick W, Buchanan P, Hallahan T.W, Krantz D.A, Larsen J.W Jr, Macri J.N. Combined first-trimester versus second-trimester serum screening for Down syndrome a cost analysis. Am J Obstet Gynecol. 188:(3):2003;745-751
20. Vintzileos A.M, Ananth C.V, Smulian J.C, Day-Salvatore D.L, Beazoglou T, Knuppel R.A. Cost-benefit analysis of prenatal diagnosis for Down syndrome using the British or the American approach. Obstet Gynecol. 95:(4):2000;577-583
21. Caughey A.B, Kuppermann M, Norton M.E, Washington A.E. Nuchal translucency and first trimester biochemical markers for Down syndrome screening a cost-effectiveness analysis. Am J Obstet Gynecol. 187:(5):2002;1239-1245
22. Christiansen M, Larsen S.O. An increase in cost-effectiveness of first trimester maternal screening programmes for fetal chromosome anomalies is obtained by contingent testing. Prenat Diagn. 22:(6):2002;482-486
23. Vintzileos A.M, Ananth C.V, Fisher A.J, et al. Cost-benefit analysis of targeted ultrasonography for prenatal detection of spina bifida in patients with an elevated concentration of second-trimester maternal serum alpha-fetoprotein. Am J Obstet Gynecol. 180:(5):1999;1227-1233
24. Vintzileos A.M, Ananth C.V, Fisher A.J, et al. An economic evaluation of prenatal strategies for detection of trisomy 18. Am J Obstet Gynecol. 179:(5):1998;1220-1224